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Conservative management (with a treatment escalation plan in case the patient deteriorates) 
is a safe alternative to interventional management of a primary spontaneous pneumothorax 
https://bit.ly/3fIN4uh
Context
For a primary spontaneous pneumothorax (PSP) 
(in a person with no underlying lung disease) with 
a visible rim of >2 cm between the lung margin 
and the chest wall (at the level of the hilum) on a 
chest radiograph, current guidelines recommend 
aspiration with a 16–18-gauge cannula and 
insertion of a small-bore chest drain (8–14 French) 
if the pneumothorax size cannot successfully be 
reduced below the 2 cm rim or the patient remains 
breathless [1]. As interventional management of 
PSP is associated with potential complications and 
a patient with a chest drain needs to be admitted to 
hospital, evaluation of conservative management 
as a potential alternative to interventional 
management of larger PSPs is desirable. Before the 
current trial, there were a few observational studies 
suggesting that moderate to large sized PSPs can 
potentially be successfully managed without 
intervention but evidence from randomised trials 
was lacking [2]. The PSP trial aimed to determine 
whether conservative management is an acceptable 
alternative to interventional management for 
uncomplicated, moderate-to-large PSP [3].
Methods
The PSP trial was a multicentre, prospective, 
randomised noninferiority trial conducted across 
39 metropolitan and rural hospitals in Australia and 
New Zealand [3]. It included 316 patients between 
the ages of 14 and 50 years who presented with 
a unilateral moderate to large PSP (≥32% or more 
on chest radiography, as measured by a volumetric 
Collins equation). Patients were randomised to a 
conservative or interventional approach. All patients 
received standard care with analgesia as needed 
and oxygen supplementation. In the conservative 
management group, patients were observed for 
a minimum of 4 h, at which time a repeat chest 
radiograph was obtained. Interventions were 
permitted in the conservative group for a number of 
prespecified conditions including pain or dyspnoea 
preventing mobilisation, haemodynamic instability, 
and radiological progression. In the intervention 
group, a small bore (≤12 French) Seldinger-
style chest tube was placed and attached to an 
underwater seal for 1 h, without suction. If the 
lung had re-expanded and there was no leak, the 
tube was clamped for 4 h and if the lung remained 
fully expanded, the chest tube was removed and 
the patient was discharged. Follow-up consisted 
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of a clinical follow-up, chest radiograph, and a 
structured interview between 24 and 72 h after 
randomisation, and again at 2, 4 and 8 weeks 
follow-up.
The primary outcome was complete radiographic 
resolution of the primary pneumothorax (full lung 
re-expansion) within 8 weeks after randomisation 
using intention-to-treat analysis. Secondary 
outcomes included the time until radiographic 
resolution, the time until resolution of symptoms, 
the risk of a recurrent pneumothorax, adverse 
events, length of hospital stay, number of invasive 
procedures and radiological investigations, number 
of days off work, persistent air leak, and patient 
satisfaction.
Main results
Of 316 patients, 154 patients were randomised to 
the intervention group and 162 to the conservative 
management group. In the intervention group, 10 
patients (6.5%) declined an intervention; in the 
conservative management group, 25 patients 
(15.4%) underwent interventions to manage the 
pneumothorax for reasons pre-specified in the 
protocol. Chest radiography follow-up at 8 weeks 
was missing for 23 patients in the intervention 
group and for 37 in the conservative management 
group. When only including patients who had 
a chest radiograph performed at 8 weeks, 129 
(98.5%) out of 131 patients having an intervention 
and 118 (94.4%) out of 125 patients managed 
conservatively had pneumothorax resolution (risk 
difference −4.1 percentage points, 95% CI −8.6–
0.5; p=0.02 for noninferiority). In this analysis, the 
lower boundary of the 95% confidence interval 
was within the prespecified noninferiority margin 
of −9 percentage points, and therefore conservative 
management was assessed as noninferior to 
interventional management. In a sensitivity analysis 
in which all missing data after 56 days were imputed 
as treatment failure (with re-expansion in 129 
(93.5%) of 138 patients in the intervention group 
and in 118 (82.5%) of 143 in the conservative-
management group), the risk difference of −11.0 
percentage points (95% CI −18.4– −3.5) was outside 
the pre-specified noninferiority margin, indicating 
that conservative management is inferior to 
interventional management. Figure 1 illustrates 
the point estimates and 95% confidence intervals 
for lung re-expansion at 8 weeks using different 
analytical methods.
The median time until radiological resolution 
was 16 days (interquartile range 12–26 days) in 
the intervention group and 30 days (interquartile 
range 25–54 days) in the conservative management 
group (hazard ratio 0.49, 95% CI 0.39–0.63). 
Complete resolution of symptoms by 8 weeks was 
reported in 128 (93.4%) out of 137 patients in the 
intervention group and in 139 (94.6%) out of 147 in 
the conservative management group. Conservative 
management also resulted in fewer hospitalisation 
days, a lower likelihood of prolonged chest tube 
drainage, less need for surgery, fewer adverse events 
and fewer pneumothorax recurrences during the 
first 12 months (25 (16.8%) out of 149 as compared 
with 14 (8.8%) of 159; absolute risk difference 8.0 
percentage points, 95% CI 0.5–15.4).
Commentary
The PSP trial is the first randomised trial to compare 
conservative with interventional management for 
moderate to large PSP. It showed that conservative 
management was noninferior (defined as 9% worse 
or less) compared with interventional management 
for lung expansion within 8 weeks when only 
patients were included who had a chest radiograph 
available at that time point but was inferior when 
missing data were imputed as treatment failure.
Almost 85% of patients in the conservative 
management group did not require any intervention 
and their symptoms resolved as quickly as the 
intervention group with fewer days in hospital, 
fewer days off work, less need for surgery and fewer 
adverse effects.
The study has significant limitations. The 
study protocol did not specify the window for the 
8-week visit or outline how missing radiographic 
data were to be handled for the primary outcome 
of pneumothorax resolution at 8 weeks. The study 
authors addressed this problem by conducting 
an analysis including only cases with complete 
follow-up data at the 8-week mark (56 days), 
as well as two sensitivity analyses to test the 
robustness of this assessment. The first sensitivity 
analysis imputed all missing data at 56 days as 
treatment failure and the second sensitivity analysis 
extended the follow-up duration to 63 days, thus 
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Figure 1 Effect size (ES) for lung re-expansion at 8 weeks using different analytical methods.
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allowing inclusion of an additional five patients 
in the intervention group and 11 patients in the 
conservative management group who had their 
chest radiograph between 56 and 63 days. As 
illustrated in figure 1, in one sensitivity analysis, 
the result did not fall within the prespecified 
noninferiority margin, therefore making the 
results for the pneumothorax resolution at 8 weeks 
uncertain. The prespecified noninferiority margin of 
−9 percent was chosen by the steering committee 
of the study and was not based on any previously 
established noninferiority margin. If this margin 
would have been −7.8 percent or less, all three 
analysis methods would have failed to establish 
noninferiority for the primary outcome.
Another limitation of the study was that the chest 
radiograph assessment for the primary outcome 
was done by the treating clinicians, who were 
aware of the trial-group assignments. Compared 
with independent radiologists who were unaware 
of the trial-group assignments (but did not assess 
all radiographs at 8 weeks), the clinicians were more 
likely to report full resolution in the group receiving 
interventional management. This bias would 
therefore have worked against overestimating the 
benefit of conservative management.
The trial was conducted across a spectrum 
of rural, urban, secondary and tertiary centres, 
making the results applicable to different healthcare 
settings. However, of 2637 patients screened for 
eligibility, only 316 underwent randomisation; 
1930 screened patients had at least one exclusion 
criterion. This indicates that the study results apply 
to a select subgroup of patients and may not be 
generalisable to the majority of patients with a 
pneumothorax. Eligible participants were young 
otherwise healthy patients with their first moderate 
to large PSP, without haemodynamic compromise.
Implications for practice
While it is uncertain based on the study results if 
conservative management of a PSP is noninferior 
to interventional management for the outcome 
of resolution within 8 weeks, the study provides 
evidence that conservative management (with 
a treatment escalation plan in case the patient 
deteriorates) is a safe alternative to interventional 
management. It is therefore reasonable to offer 
patients comparable to those included in the study 
(aged between 14 and 50 years with a unilateral 
moderate to large PSP) a conservative management 
approach. The best course of action in patients 
who are clinically stable and, therefore, potentially 
eligible for conservative management should be 
evaluated together with the patient, taking into 
account the patient’s values and preferences. The 
possible advantages of less adverse events, a shorter 
hospital stay and a reduced risk of a recurrent 
pneumothorax within 1 year with conservative 
management have to be weighed against the 
prolonged time to radiographic resolution, which, 
for example, delays fitness to fly and the ability to 
safely lift heavy objects. Different patients will weigh 
these outcomes differently; for example, somebody 
who has a flight booked in 5 weeks might value 
a quick resolution of the pneumothorax more, 
while another person is happy to wait longer for 
pneumothorax resolution if that means that they 
do not have to stay in hospital and have a lower risk 
of having another pneumothorax once it is healed.
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